Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

Clinical Cancer Research

Volumn 19, Issue 5, 2013, Pages 1190-1196

  Italiano, Antoine ^a   Lagarde, Pauline ^a   Brulard, Céline ^a   Terrier, Philippe ^b   Laë, Marick ^c   Marques, Bernard ^d   Ranchere Vince, Dominique ^e   Michels, Jean Jacques ^f   Trassard, Martine ^g   Cioffi, Angela ^b   Piperno Neumann, Sophie ^c   Chevreau, Christine ^d   Blay, Jean Yves ^e   Delcambre, Corinne ^f   Isambert, Nicolas ^h   Penel, Nicolas ⁱ   Bay, Jacques Olivier ^j   Bonvalot, Sylvie ^b   Le Cesne, Axel ^b   Coindre, Jean Michel ^a   Chibon, Frédéric ^a   more..

^a INSTITUT BERGONIÉ   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e CENTRE LÉON BÉRARD   (France)

^f CENTRE FRANÇOIS BACLESSE   (France)

^g CENTRE RENÉ HUGUENIN   (France)

^h CENTRE GEORGES FRANÇOIS LECLERC   (France)

ⁱ CENTRE OSCAR LAMBRET   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DNA; DOXORUBICIN; IFOSFAMIDE; MESNA; MYOCARDIN; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELL ADHESION; COMPARATIVE GENOMIC HYBRIDIZATION; CONFIDENCE INTERVAL; EXTRACELLULAR MATRIX; EXTREMITIES LEIOMYOSARCOMA; FEMALE; FOLLOW UP; FRANCE; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MULTIVARIATE ANALYSIS; MUSCLE RESECTION; MYOCD GENE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROPERITONEAL LEIOMYOSARCOMA; SOFT TISSUE CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMBINED MODALITY THERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; LEIOMYOSARCOMA; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84874829740     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2970     Document Type: Article

References (33)

1. Fletcher C, Unni K, Mertens F, eds. World Health Organization classification of tumours pathology and genetics of tumours of soft tissue and bone. Lyon, France: IARC Press; 2002.
2. Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M, Rydholm A. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992;70: 114-9.
3. Miyajima K, Oda Y, Oshiro Y, Tamiya S, Kinukawa N, Masuda K, et al. Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis. Histopathology 2002;40: 353-9.
4. Farshid G, Pradhan M, Goldblum J, Weiss SW. Leiomyosarcoma of somatic soft tissues. A tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol 2002;26: 14-24.
5. Mankin HJ, Casas-Ganem J, Kim JI, Gebhardt MC, Hornicek FJ, Zeegen EN. Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res 2004;1: 225-31.
6. Massi D, Beltrami G, Mela MM, Pertici M, Capanna R, Franchi A. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases. Eur J Surg Oncol 2004;30: 565-72.
7. Svarvar C,Böhling T, Berlin O, Gustafson P, Folleras G, Bjerkehagen B, et al. Scandinavian Sarcoma Group Leiomyosarcoma Working Group. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer 2007;109: 282-91.
8. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002;359: 1301-7.
9. Shmulevich I, Hunt K, El-Naggar A, Taylor E, Ramdas L, Laborde P, et al. Tumor specific gene expression profiles in human leiomyosarcoma: an evaluation of intratumor heterogeneity. Cancer 2002;94: 2069-75.
10. Ren B, Yu YP, Jing L, Liu L, Michalopoulos GK, Luo JH, et al. Gene expression analysis of human soft tissue leiomyosarcomas. Hum Pathol 2003;34: 549-58.
11. Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 2003;163: 691-700.
12. Skubitz KM, Skubitz AP. Differential gene expression in leiomyosarcoma. Cancer 2003;98: 1029-38.
13. Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton CC. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer 2004;40: 97-108.
14. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, et al. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 2007;20: 749-59.
15. Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 2005;65: 9226-35.
16. Henderson SR, Guiliano D, Presneau N, McLean S, Frow R, Vujovic S, et al. A molecular map of mesenchymal tumors. Genome Biol 2005;6: R76.
17. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namlos HM, et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 2006;66: 8984-93.
18. Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 2010;29: 845-54.
19. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15: 350-62.
20. Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 2007;9:R24.
21. La Rosa P, Viara E, Hupé P, Pierron G, Liva S, Neuvial P, et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006;22: 2066-73.
22. WuZ, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F.Amodel based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004;99: 909-17.
23. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33: 37-42.
24. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol 1991;9: 191-2.
25. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, et al. Children's Oncology Group. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 2008;51: 334-8.
26. Gelderblom H, Jinks RC, Sydes M, Bramwell VH, van Glabbeke M, Grimer RJ, et al. European Osteosarcoma Intergroup. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur JCancer 2011;47: 895-902.
27. Italiano A, Mathoulin-Pelissier S, Cesne AL, Terrier P, Bonvalot S, Collin F, et al. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer 2011;117: 1049-54.
28. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, et al. French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001;92: 359-68.
29. Abbott AM, Habermann EB, Parsons HM, Tuttle T, Al-Refaie W. Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis. Cancer 2012;118: 3321-9.
30. Pérot G, Derré J, Coindre JM, Tirode F, Lucchesi C, Mariani O, et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res 2009;69: 2269-78.
31. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 2003;100: 7129-34.
32. Pipes GC, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 2006;20: 1545-56.
33. Chibon F, Lagarde P, Salas S, Pérot G, Brouste V, Tirode F, et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010;16: 781-7.